Clonidine Decreases Plasma Catecholamines and Improves Outcome From Incomplete Ischemia in the Rat

Clonidine decreases central sympathetic activity and anesthetic requirement. We tested whether clonidine improves outcome from incomplete ischemia of the brain in rats. Control rats were anesthetized with 25 μg·kg−1·h−1 of intravenous fentanyl and inhalation of 70% nitrous oxide (N2O). Clonidine-treated rats received fentanyl/N2O and 10 μg/kg of intravenous clonidine 10 min before ischemia, which was produced by right carotid ligation combined with hemorrhagic hypotension to 35 mm Hg for 30 min. Clonidine increased plasma glucose before ischemia and decreased blood catecholamine concentrations during ischemia compared with the control group. Neurologic outcome was evaluated daily for 3 days after ischemia and histopathology was performed at the end of this period. Clonidine significantly improved neurologic outcome on each of the 3 days after ischemia. Histopathology was severe in the control group but not enough rats survived in this group for statistical analysis. The authors conclude mat donidine decreases sympathetic activity during ischemia and that this is associated with an improvement in outcome from incomplete ischemia.

[1]  W. Hoffman,et al.  Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole. , 1991, Anesthesiology.

[2]  M. Maze,et al.  Alpha‐2 Adrenoceptor Agonists: Defining the Role in Clinical Anesthesia , 1991, Anesthesiology.

[3]  T. Wieloch,et al.  Protection against Ischemia-Induced Neuronal Damage by the α2-Adrenoceptor Antagonist Idazoxan: Influence of Time of Administration and Possible Mechanisms of Action , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  W. Hoffman,et al.  Ganglionic blockade improves neurologic outcome from incomplete ischemia in rats: partial reversal by exogenous catecholamines. , 1990, Anesthesiology.

[5]  W. Hoffman,et al.  Brain lactate and neurologic outcome following incomplete ischemia in fasted, nonfasted, and glucose-loaded rats. , 1990, Anesthesiology.

[6]  J. Becquemin,et al.  Aortic surgery: effect of clonidine on intraoperative catecholaminergic and circulatory stability , 1990, Acta anaesthesiologica Scandinavica.

[7]  R. Busto,et al.  Direct Evidence for Acute and Massive Norepinephrine Release in the Hippocampus during Transient Ischemia , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  M. Miyazaki,et al.  Inhibition of ischemia-induced brain catecholamine alterations by clonidine , 1989, Brain Research Bulletin.

[9]  I. Kopin,et al.  Evidence for a direct peripheral effect of clonidine on the norepinephrine release in vivo in pithed rats. , 1988, European journal of pharmacology.

[10]  E. Conway,et al.  CLONIDINE: UNDERSTANDING ITS DISPOSITION, SITES AND MECHANISM OF ACTION , 1987, Clinical and experimental pharmacology & physiology.

[11]  B. Siesjö,et al.  Circulating Catecholamines Modulate Ischemic Brain Damage , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  M. Scheinin,et al.  alpha 2-Adrenoceptor agonists decrease free 3-methoxy-4-hydroxyphenylglycol in rat cerebrospinal fluid. , 1986, European journal of pharmacology.

[13]  R. Busto,et al.  Cerebal norepinephrine depletion enhances recovery after brain ischemia , 1985, Annals of neurology.

[14]  J. Weinberger,et al.  Nerve terminal damage in cerebral ischemia: protective effect of alpha-methyl-para-tyrosine. , 1985, Stroke.

[15]  O. Lindvall,et al.  Lesions of the locus coeruleus system aggravate ischemic damage in the rat brain , 1985, Neuroscience Letters.

[16]  E. Kinik,et al.  Nifedipine in hypertensive emergencies. , 1983, British medical journal.

[17]  R. Cracco,et al.  Cortical injury without ischemia produced by topical monoamines. , 1982, Stroke.

[18]  T. Katada,et al.  Slow interaction of islet-activating protein with pancreatic islets during primary culture to cause reversal of alpha-adrenergic inhibition of insulin secretion. , 1980, The Journal of biological chemistry.

[19]  C. Carlsson,et al.  Cerebral Oxygen Consumption and Blood Flow in Hypoxia: Influence of Sympathoadrenal Activation , 1979, Stroke.